StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.01−0.01 (-0.50%)

Close on Nov 17, 2026Market cap $14.81MP/E –Yield –

GeoVax Labs operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

GeoVax Labs's operating cash flow for the twelve months ending Jun 30, 2026 was -$18.37M. For fiscal 2025 it was -$21.47M. The highest annual figure on record is -$303.62K in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.47M–
FY2024Dec 31, 2024-$24.68M–
FY2023Dec 31, 2023-$25.17M–
FY2022Dec 31, 2022-$19.03M–
FY2021Dec 31, 2021-$11.20M–
FY2020Dec 31, 2020-$2.75M–
FY2019Dec 31, 2019-$1.40M–
FY2018Dec 31, 2018-$1.54M–
FY2017Dec 31, 2017-$1.69M–
FY2016Dec 31, 2016-$1.95M–
FY2015Dec 31, 2015-$2.71M–
FY2014Dec 31, 2014-$2.25M–
FY2013Dec 31, 2013-$1.69M–
FY2012Dec 31, 2012-$2.44M–
FY2011Dec 31, 2011-$303.62K–
FY2010Dec 31, 2010-$2.44M–
FY2009Dec 31, 2009-$1.43M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.66M–
Q1 FY2026Mar 31, 2026-$3.54M–
Q4 FY2025Dec 31, 2025-$4.96M–
Q3 FY2025Sep 30, 2025-$6.21M–
Q2 FY2025Jun 30, 2025-$4.33M–
Q1 FY2025Mar 31, 2025-$5.97M–
Q4 FY2024Dec 31, 2024-$7.75M–
Q3 FY2024Sep 30, 2024-$9.30M–
Q2 FY2024Jun 30, 2024-$1.94M–
Q1 FY2024Mar 31, 2024-$5.68M–
Q4 FY2023Dec 31, 2023-$10.28M–
Q3 FY2023Sep 30, 2023-$5.10M–
Q2 FY2023Jun 30, 2023-$6.04M–
Q1 FY2023Mar 31, 2023-$3.76M–
Q4 FY2022Dec 31, 2022-$7.06M–
Q3 FY2022Sep 30, 2022-$3.80M–
Q2 FY2022Jun 30, 2022-$3.83M–
Q1 FY2022Mar 31, 2022-$4.33M–
Q4 FY2021Dec 31, 2021-$6.68M–
Q3 FY2021Sep 30, 2021-$1.63M–
Q2 FY2021Jun 30, 2021-$1.26M–
Q1 FY2021Mar 31, 2021-$1.62M–
Q4 FY2020Dec 31, 2020-$1.54M–
Q3 FY2020Sep 30, 2020-$283.13K–
Q2 FY2020Jun 30, 2020-$566.87K–
Q1 FY2020Mar 31, 2020-$358.62K–
Q4 FY2019Dec 31, 2019-$280.76K–
Q3 FY2019Sep 30, 2019-$343.93K–
Q2 FY2019Jun 30, 2019-$456.45K–
Q1 FY2019Mar 31, 2019-$317.36K–
Q4 FY2018Dec 31, 2018-$501.54K–
Q3 FY2018Sep 30, 2018-$279.73K–
Q2 FY2018Jun 30, 2018-$380.19K–
Q1 FY2018Mar 31, 2018-$381.57K–
Q4 FY2017Dec 31, 2017-$448.44K–
Q3 FY2017Sep 30, 2017-$478.77K–
Q2 FY2017Jun 30, 2017-$429.15K–
Q1 FY2017Mar 31, 2017-$332.10K–
Q4 FY2016Dec 31, 2016-$368.44K–
Q3 FY2016Sep 30, 2016-$403.26K–

More GeoVax Labs figures

See a number that looks wrong?